Slow Capital Inc. Increases Position in The Clorox Company (NYSE:CLX)

Slow Capital Inc. boosted its holdings in shares of The Clorox Company (NYSE:CLX) by 0.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,320 shares of the company’s stock after acquiring an additional 105 shares during the period. Slow Capital Inc.’s holdings in Clorox were worth $2,984,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of CLX. Innealta Capital LLC acquired a new position in Clorox in the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC boosted its holdings in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. GoalVest Advisory LLC acquired a new position in Clorox in the 1st quarter valued at about $31,000. First Foundation Advisors acquired a new position in Clorox in the 1st quarter valued at about $31,000. Finally, Family Firm Inc. acquired a new position in Clorox in the 2nd quarter valued at about $31,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Down 0.4 %

Shares of NYSE:CLX opened at $161.96 on Friday. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09. The company’s 50 day moving average is $159.28 and its two-hundred day moving average is $145.18. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The company has a market cap of $20.11 billion, a PE ratio of 83.92, a P/E/G ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. Equities analysts predict that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.01%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 252.85%.

Wall Street Analysts Forecast Growth

CLX has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Barclays upped their price objective on shares of Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. Finally, DA Davidson restated a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. Six research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Clorox presently has a consensus rating of “Hold” and an average price target of $150.14.

Insider Activity at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.51% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.